PCI in Nonagenarians: Age Is Just a Number
The outcomes of percutaneous coronary intervention (PCI) in nonagenarians is an understudied topic. A recent observational study published in the Journal of American College of Cardiology has looked into the…
Optimal IVUS Guidance for Stent Placement: A Clear Winner?
The results of the ULTIMATE trial, presented at the TCT conference 2018, have shown that IVUS-guided PCI is superior to angiography-guided PCI in the prevention of target vessel failure in…
How Accurate is the Fractional Flow Reserve Derived From Routine Coronary Angiography?
The FAST-FFR study conducted by Fearon and his colleagues, and presented at the annual TCT conference 2018, has shown that Fractional Flow Reserve (FFRangio) measured from the coronary angiogram alone has a…
Tricuspid Edge-to-Edge Valve Repair Safe in Patients with Torrential Tricuspid Regurgitation
Results from a subgroup analysis of the TriValve Registry presented at TCT 2018 showed that interventional tricuspid edge-to-edge valve repair was safe with improvement in outcomes in patients, with high…
Corevalve Evolut R (Medtronic) and Edwards Sapien 3 (Edward Lifesciences) Valves Reveal Equivalence in Transcatheter Aortic Valve Implantation (TAVI) in a Head-to-Head Comparison
Results from an open-label, multi-center, 2x2 factorial design randomized trial powered for equivalence, comparing the self-expanding Corevalve Evolut R valve to balloon expandable Edwards Sapien 3 valve, have shown that…
Landmark COAPT trial Demonstrates the Benefit of Transcatheter Mitral-Valve Repair Using MitraClip in Patients with Heart Failure
The spectacular results of the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) trial, presented at TCT 2018, show that transcatheter…
Polymer-Free Amphilimus-Eluting stents: A Novel Elution Technology
Polymer-free amphilimus-eluting stents (PF-AES) are non-inferior to permanent-polymer zotarolimus-eluting stents (PP-ZES) in terms of target-lesion failure at 12 months, according to the results of the ReCre8 study, presented by Pieter R.…
Polymer coated sustained-release Eluvia DES outshines non-polymer coated Zilver DES for femoropopliteal artery stenosis
A randomized global, prospective, multi-center, single-blind trial comparing the Eluvia paclitaxel-eluting stent (Boston Scientific) to Zilver PTX paclitaxel-eluting stent (Cook Medical) has shown that the Eluvia stent outperformed Zilver in…
SORT-OUT and BIONYX Successfully Demonstrate Non-Inferiority in the World of Drug-Eluting Stents
Findings from the SORT-OUT trial, presented at the 30th annual Transcatheter Cardiovascular Therapeutics (TCT) conference 2018 held at San Diego, showed that at 12 months, polymer free Biolimus A9-coated BioFreedom…
Vascular Video Series Part 6: Gaps in Vascular Care
This video is supported by an unrestricted educational grant.
Physician burnout: An Emerging National Epidemic
Results of two studies published in the latest issue of the JAMA have focussed on the syndrome of physician burnout and rates of career choice regret within the US medical…
Apple Watch Series 4 Receives FDA Approval as a Class II Medical Device
The Apple watch series 4 received FDA approval as a class II medical device. Apple claims that the device can detect falls and arrhythmias. It can also record an electrocardiogram…
Vascular Video Series Part 5: Gaps in Vascular Care
This video is supported by an unrestricted educational grant.
Early Discharge Following Uncomplicated TAVR Safe, According to a Meta-Analysis
A recent meta-analysis published in the Journal of American College of Cardiology has shown that early discharge (ED) after uncomplicated Transaortic valve replacement (TAVR) is safe and has no negative…
ASPREE: Another Warning Bell for Aspirin, “Wonder Drug”Fails to Work Wonders
The results of the Aspirin in Reducing Events in the Elderly (ASPREE) trial published in the New England Journal of Medicine showcase higher all-cause mortality among apparently healthy older adults…
Do Valsartan Contaminants NDMA and NDEA Bear A Potential Cancer Risk?
The discovery of Valsartan products that were contaminated with NDMA, in July 2018, in drug products manufactured in China, triggered the withdrawal of all affected products by medical agencies across…
Vascular Video Series Part 4: Vascular Risk
This video is supported by an unrestricted educational grant.
Can TTR levels Determine Long-term Prognosis in AFib Patients on Vitamin K Antagonists?
Findings from a Danish nationwide registry conducted among patients with Atrial Fibrillation (AF), initiated on Vitamin K Antagonists (VKA) for stroke prevention between 1997 and 2011, found that almost one-half…
Operator Experience of Atleast 225 Procedures Associated With Improved TAVR Outcomes
Findings from an international TAVR registry involving 16 centers and spanning over a decade have important implications for operator training and patient care at centers performing TAVR. The study, published…
Vascular Video Series Part 3: The Polyvascular Disease Patient
This video is supported by an unrestricted educational grant.